Czech government's move to cut drug costs sparks protestsBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7482.62-c (Published 06 January 2005) Cite this as: BMJ 2005;330:62
- Katka Krosnar
Doctors' and patients' representatives say they fear that psychiatric care in the Czech Republic could be seriously hampered by a new health ministry directive seeking to restrict the range of available drugs.
Access to second generation antipsychotic drugs for patients with schizophrenia will be limited under measures promoting the use of cheaper generic drugs over brand name drugs for some types of treatment from January. The Czech doctors' union Lok supports the move, because of the need to save money, but groups representing psychiatrists are opposing it.
“Restricting the entire range of newly developed medication is not fair to patients. People and their diseases are very different, and it should be down to doctors, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial